Having trouble reading this email? View the web version here  |  Forward this email to a colleague

Facebook Like Button Tweet Button
European Pharmaceutical Review Follow us on Twitter
Join us on LinkedIn

Metabolic Assessment on a Plate Reader

Highly sensitive Oxygen and pH monitoring solutions for your metabolic testing needs

The Luxcel MitoXpress® assays offer the convenience of a micro-titre plate format which can be analysed on fluorescence plate readers.

The ideal tool for:

- Intra-cellular and extracellular oxygen analysis assessment

- Oxygen monitoring in Hypoxia research

- For the analysis of a wide variety of respiring systems including isolated mitochondria and whole cells


Multiparametric analysis can be achieved using both the MitoXpress® and pH assays-simultaneously measuring oxygen consumption and extracellular acidification changes on a plate reader.

Areas of Application include:

Metabolism
Cancer research
Mitochondrial function
Drug Toxicity

Find out more

ISSCR 10th Annual Meeting

Registration is open! 

Register now to join the ISSCR in Yokohama, Japan, June 13 -16, 2012, where the world leaders in stem cell science will meet to discuss their original, innovative research. Submit an abstract to present your work at the year’s premier stem cell research event. Visit www.isscr.org/2012 for more information.

Find out more

Company Directory

Premium & Premium+ listings:

- ABB Analytical Measurements
- Almac
- BD Diagnostics
- Bio-Optronics, Inc.
- bioMérieux
- BioTek Instruments, Inc.
- Bruker Daltonik GmbH
- CAMO Software AS
- CI Precision
- Cisbio Bioassays
- Colder Products Company
- Expo Technologies, LLC.
- Freeman Technology
- GE Analytical Instruments
- HACH LANGE GMBH
- HORIBA Scientific
- Hudson Robotics, Inc.
- Natoli Engineering Company, Inc.
- Peter Huber Kältemaschinenbau GmbH
- Randox Pharma Services
- Rapid Micro Biosystems
- Smithers Viscient
- Synbiosis
- Syngene
- Watson-Marlow Pumps Group

Add your company

Private and public partners unite to combat 10 neglected tropical diseases by 2020

13 pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organisations have announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade...

Read the full story >>

  Bill & Melissa Gates

More pharmaceutical & life science news

AstraZeneca to cut a further 7,300 jobs
AstraZeneca has announced new restructuring initiatives designed to improve productivity...

FDA approves Novartis drug Glivec® label
The US Food and Drug Administration has approved an update to the Glivec® (imatinib)* label...

Sanofi commits to eliminate or control five neglected tropical diseases
These commitments are a key part of the "Uniting to Combat Neglected Tropical Diseases" partnership...

Novartis extends commitment to help achieve final elimination of leprosy
Novartis is a part of an international effort to eliminate or control 10 NTDs by the end of the decade...

FDA approves Jentadueto™ (linagliptin/metformin hydrochloride) tablets for the treatment of adult patients with type 2 diabetes
Jentadueto™ tablets approved...

Biogen Idec appoints Kenneth DiPietro Executive Vice President Human Resources
Kenneth DiPietro named Executive Vice President, Human Resources...

FDA approves Erivedge (vismodegib) capsule
The first medicine for adults with advanced basal cell carcinoma...

GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020
“United effort to free future generations from the burden of neglected tropical diseases..."

DNDi and Abbott expand partnership to boost innovation for neglected tropical diseases
DNDi & Abbott have signed a four-year joint research & non-exclusive licensing agreement...

Roche commences tender offer for Illumina, Inc. for $44.50 per share in cash
Roche has commenced a cash tender offer to acquire all outstanding shares of Illumina, Inc...

Pfizer announces FDA acceptance of New Drug Application for Bosutinib
The U.S. FDA has accepted its NDA for standard review of bosutinib...

Featured supplier news

Syrris custom reactors – built for you
Syrris Custom Reactor Systems are ideally suited to processes requiring large reactor vessels...

B&W Tek to introduce spectral data acquisition software at SPIE’s BiOS & Photonics West Exhibits
B&W Tek, Inc., is proud to introduce BWSpec™ 4.00...

FOSS releases new features for Vision
Service Pack 7 has been released for Vision 3.50, a software package designed for use with the FOSS NIRSystems Near-Infrared laboratory and process analyzers...

B&W Tek to introduce micro lensed fiber-optic Raman probe at SPIE’s BiOS & Photonics West exhibits
B&W Tek, Inc., is proud to introduce the BAC200...

Conferences, events & exhibitions:

Drug Discovery for Neurodegeneration
12 - 14 February 2012, New York, USA

4th International Conference on Drug Discovery and Therapy
12 - 15 February 2012, Dubai, UAE

9th Annual PAT and Quality by Design
20 - 22 February 2012, London, UK

7th Annual Biomarkers Congress
22 - 23 February 2012, Manchester, UK

BIA Research & Development Conference
28 February 2012, London, UK